TVRD
NASDAQ · Pharmaceuticals
Tvardi Therapeutics Inc
$2.56
+0.14 (+5.79%)
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,387.1% upside
Low Target
$23.38
Average Target
$38.07
High Target
$43.34
Current Price
$2.56
Current
$2.56
$2.56
Target
$38.07
$38.07
$23.38
$38.07 avg
$43.34
Scenario Analysis
Bear Case
$23.38
813.3%
Low target
Base Case
$38.07
+1,387.1%
Avg target
Bull Case
$43.34
+1,593.0%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$43.65
-94.1% from high
52-Week Low
$2.48
+3.4% from low
Target vs 52W High
$38.07
-12.8% vs high
Peer Consensus — Pharmaceuticals